CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers - Wikidata - awgldk - TriplyDB

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

http://www.wikidata.org/entity/Q34034939

about

Cancer stem cells (CSCs), cervical CSCs and targeted therapies The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer Therapies targeting cancer stem cells: Current trends and future challenges Therapeutic strategies targeting cancer stem cells CD44 as a potential diagnostic tumor marker Data management strategies for multinational large-scale systems biology projects CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions Phosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scattering A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance Buoyancy-activated cell sorting using targeted biotinylated albumin microbubbles.Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.A 41-gene signature derived from breast cancer stem cells as a predictor of survival.The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway.DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles.Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.A summary of relationships between alternative splicing and breast cancer.Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies.Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand.Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.Glycerophosphoglycerol, Beta-alanine, and pantothenic Acid as metabolic companions of glycolytic activity and cell migration in breast cancer cell lines.Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.Monoclonal antibodies against human cancer stem cells.Deregulation of splicing factors and breast cancer development.Stem cells - biological update and cell therapy progress.Alternative Pre-mRNA Splicing in Mammals and Teleost Fish: A Effective Strategy for the Regulation of Immune Responses Against Pathogen Infection.Hyaluronic Acid Nanohydrogel Loaded With Quercetin Alone or in Combination to a Macrolide Derivative of Rapamycin RAD001 (Everolimus) as a New Treatment for Hormone-Responsive Human Breast Cancer.

P2860

Q26747144-A032A9A2-38D8-47F7-8C36-092DFEF56B84 Q26747319-0449984C-048C-4B32-BA46-C0C74B17F3D1 Q26773907-064A9742-3AE9-4FA0-B850-309AE49EAD06 Q26777880-5A8240CF-784B-4F42-B69E-F6BD7D09954C Q26781398-424F0EF7-49CA-4B9A-8C73-DAF9A4674726 Q26866085-66D36789-ABE7-4BCC-A15D-799271260082 Q27009050-6CE06836-1507-42B4-8666-DBCB96D12315 Q28250164-BF36AEBF-CA25-4445-BCEE-EF4DE6668977 Q28255119-1F14988E-15A6-4730-85FB-CB7D7420E5FF Q28543175-7CA6AA87-EE82-4170-A3DB-17C1166DB9E8 Q30410757-62F85BDD-F3EE-459A-9096-78519C9B1FF9 Q33759701-619FFADA-5E7E-4957-8F18-3CB4BBD0AC7D Q33864348-10D3C8BF-3ECB-4A5F-B3AB-7AFCED099067 Q33993634-1CC6E3B8-C609-41BE-8332-668FEA3A7CAA Q34421055-0B2804F3-D12F-4C33-A68D-3C00C3D3BA66 Q34500627-4B253E7F-AA36-47EB-A559-7368BE5E60EA Q34606294-F47B3C0E-2F27-4830-BE72-AFEBF240C9BD Q35106226-2015E02C-C4E0-450A-BDA6-8E399A8BCB35 Q35795934-54400EE7-BD7B-4E52-8B1D-A00689A0D43A Q35804266-02E857CC-9B1F-4530-B044-0DE565D926D2 Q35932396-A3B4935D-A7A9-48BA-AE24-9FAE0058E595 Q36103082-EADB5BA8-38B2-4FC8-B796-B86ECF06EAD0 Q36355925-CC8D2176-1C6E-4D98-872F-85403CC13CB4 Q36378283-2DA97099-2512-4954-BE81-D7ABE45CD6D7 Q36394240-964485D9-CA57-4D71-9133-FC685878BBD2 Q36405638-BF9356B7-6362-43B6-84F7-5BAE4E8272BC Q36544248-66BE4169-F5C9-46C5-B538-73ABBB996461 Q36821154-51F2BFEE-7DDB-44C7-84FF-DBD3EF327796 Q37098317-26D5C943-3FA1-4666-8C6E-EC6DD27DA796 Q37145661-049974D6-4346-410C-A23C-B02ACC11A1B3 Q37288727-EA827341-919B-45F1-8619-8B2F7C259C7A Q37608829-C92B7393-D6EF-4418-BEC4-EFBD4346B702 Q37689609-CDACC259-6ED1-42A8-9F67-E50362F75BE6 Q37690517-B1045A6D-FE1E-47DE-9FD2-8B7047192768 Q37708863-FE2BBB2A-F161-400C-ADBE-0491570D7C28 Q38206818-3380C855-40C0-4792-9296-4645EB713DBA Q38463397-7D275639-D0E2-4A2E-98EB-712CE1289AF1 Q38648343-5F24E91A-B546-410F-A7F4-AE6882148696 Q38656528-E642F9DC-A818-47F1-AF58-B52DF13AA999 Q38747583-AB7C6117-9FE3-4FE9-A71A-D212C7075403

P2860

CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

http://www.wikidata.org/entity/Q34034939

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@ast

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@en

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@nl

type

label

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@ast

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@en

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@nl

prefLabel

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@ast

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@en

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@nl

P1433

Q34034939-50EE22F3-7B39-42AD-A8D6-FCB2338C512F

P1476

Q34034939-F514F30C-8CD3-4275-A75E-6C0E35063E17

P2093

Q34034939-165D4F85-85E2-441F-84F9-AAED7034AB74

Q34034939-21F3F92D-D1F8-4C95-A6D1-2C44BA1C4B12

Q34034939-431B587A-68EB-4E60-8C53-12DC7C86F33A

Q34034939-5C4172C4-17D6-4F4E-898A-A43CF4EC8771

Q34034939-5F1F1975-9614-415E-9AFB-9F1678BE708A

Q34034939-63301D57-D468-4B52-B599-40468ABD9025

Q34034939-849D2A8A-C886-4AB2-8B97-4FCA69F63EB4

Q34034939-9460FA8B-9B31-4BBB-8138-29D68AC0D812

Q34034939-C6FA556F-8C34-40FD-8287-99520F71E9C4

Q34034939-D4F39F2E-F10E-4417-B068-1E69100E7B51

P2860

Q34034939-17038B19-6DE0-4921-8A09-27A43CAB2B1A

Q34034939-1B569CF3-FC32-4C11-80AE-A70682ABC501

Q34034939-243627DB-E875-4286-9BBE-C518FFD81B19

Q34034939-264C89A6-2D0F-40E0-BD20-55D7A5355F3F

Q34034939-28F29691-59CC-4AAB-96C7-1506AB7F59F9

Q34034939-2AD3F42E-C0EF-47F6-B331-5B50441F06B8

Q34034939-3098A1B8-970A-446B-851E-2A5840A08E12

Q34034939-3589CFA2-44FE-4107-8783-98917C4A682A

Q34034939-38A589DA-1EAB-479D-920A-C589D047744C

Q34034939-3D5C36F1-2083-4A08-838B-9A87ED29140E

P2888

Q34034939-3B587C22-55FF-41CC-B578-7D1CE0AE81A9

P304

Q34034939-893D5C1A-FF42-4A10-8D09-BE0BAB27DF10

P31

Q34034939-A7B00F37-253B-4395-A5F8-5799B68ACB66

P356

Q34034939-D7D1E8CE-E8D1-4D8F-B2BA-D9779F5BAF10

P407

Q34034939-F8914035-9E43-4E9F-AB81-5A38718A18C3

P478

Q34034939-023C1B1C-CD25-496C-B524-92BA39CD4B74

P50

Q34034939-6B3B324B-0055-4B74-B8E1-3C5B2BDC6CA5

Q34034939-8563A314-2B55-403C-9756-2301DF081682

Q34034939-95A8B410-1039-4290-A8B8-48AA082E5797

Q34034939-9ACD6415-983E-4040-84F3-E4001BA8CE66

P577

Q34034939-C9E7F17C-D42F-439A-BAC8-888B4A7D4230

P5875

Q34034939-73F4B72F-1A4F-402C-A9D1-9999D371D775

P6179

Q34034939-5DFF81A8-191C-4AE0-83E3-1AD3F8B24B00

P698

Q34034939-33D0606D-D4AC-45F1-BD25-CE0E16C305F5

P932

Q34034939-C897C09A-3BEE-4665-AAE5-93D5A6F12272

P356

1471-2407-11-418

P1433

P1476

CD44 isoforms are heterogeneou ...... s and cancer stem cell markers

@en

P2093

Ake Borg

http://www.w3.org/2001/XMLSchema#string

Cecilia Hegardt

http://www.w3.org/2001/XMLSchema#string

Dorthe Grabau

http://www.w3.org/2001/XMLSchema#string

Eleonor Olsson

http://www.w3.org/2001/XMLSchema#string

Gabriella Honeth

http://www.w3.org/2001/XMLSchema#string

Göran Jönsson

http://www.w3.org/2001/XMLSchema#string

Karolina Holm

http://www.w3.org/2001/XMLSchema#string

Kristina Lövgren

http://www.w3.org/2001/XMLSchema#string

Mårten Fernö

http://www.w3.org/2001/XMLSchema#string

Pär-Ola Bendahl

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

CD44: from adhesion molecules to signalling regulators

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

P2888

1471-2407-11-418

P304

418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-418

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Johan Vallon-Christersson

Markus Ringnér

Sofia Gruvberger

P577

2011-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51680319

http://www.w3.org/2001/XMLSchema#string

P6179

1012446249

http://www.w3.org/2001/XMLSchema#string

P698

21957977

http://www.w3.org/2001/XMLSchema#string

P932

3196967

http://www.w3.org/2001/XMLSchema#string